David Anthony Barda

Person

Indianapolis, IN, US

People

Patents Grantslast 30 patents

Information Patent Grant
KRas G12C inhibitors
- Patent number 10,968,214
- Issue date Apr 6, 2021
- Eli Lilly and Company
- David Anthony Barda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PI3 kinase/mTOR dual inhibitor
- Patent number 8,658,668
- Issue date Feb 25, 2014
- Eli Lilly and Company
- David Anthony Barda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PI3 kinase/mTOR dual inhibitor
- Patent number 8,440,829
- Issue date May 14, 2013
- Eli Lilly and Company
- David Anthony Barda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazo[1,2-A]pyridine compounds as VEGF-R2 inhibitors
- Patent number 7,666,879
- Issue date Feb 23, 2010
- Eli Lilly and Company
- David Anthony Barda
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of...
- Patent number 7,449,477
- Issue date Nov 11, 2008
- Eli Lilly and Company
- David Anthony Barda
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of Akt (protein kinase B)
- Patent number 7,414,063
- Issue date Aug 19, 2008
- Eli Lilly and Company
- Rima Salim Al-Awar
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED FUSED AZINES AS KRAS G12D INHIBITORS
- Publication number 20240228511
- Publication date Jul 11, 2024
- Eli Lilly and Company
- David Anthony BARDA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
KRAS INHIBITORS
- Publication number 20240043451
- Publication date Feb 8, 2024
- Eli Lilly and Company
- David Anthony BARDA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
KRAS G12C INHIBITORS
- Publication number 20200115375
- Publication date Apr 16, 2020
- Eli Lilly and Company
- David Anthony BARDA
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PI3 KINASE/mTOR DUAL INHIBITOR
- Publication number 20130237562
- Publication date Sep 12, 2013
- Eli Lilly and Company
- David Anthony Barda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PI3 KINASE/mTOR DUAL INHIBITOR
- Publication number 20120184577
- Publication date Jul 19, 2012
- Eli Lilly and Company
- David Anthony Barda
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS VEGF-R2 INHIBITORS
- Publication number 20090227622
- Publication date Sep 10, 2009
- David Anthony Barda
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Inhibitors of akt (protein kinase b)
- Publication number 20070043040
- Publication date Feb 22, 2007
- Rima Salim Al-Awar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
7-Phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of...
- Publication number 20070037796
- Publication date Feb 15, 2007
- David Anthony Barda
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Potentiators of glutamate receptors
- Publication number 20040006114
- Publication date Jan 8, 2004
- Darrell Stephen Coleman
- C07 - ORGANIC CHEMISTRY

David Anthony Barda

Person

Patents Grantslast 30 patents

KRas G12C inhibitors

PI3 kinase/mTOR dual inhibitor

PI3 kinase/mTOR dual inhibitor

Imidazo[1,2-A]pyridine compounds as VEGF-R2 inhibitors

7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of...

Inhibitors of Akt (protein kinase B)

Patents Applicationslast 30 patents

SUBSTITUTED FUSED AZINES AS KRAS G12D INHIBITORS

KRAS INHIBITORS

KRAS G12C INHIBITORS

PI3 KINASE/mTOR DUAL INHIBITOR

PI3 KINASE/mTOR DUAL INHIBITOR

IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AS VEGF-R2 INHIBITORS

Inhibitors of akt (protein kinase b)

7-Phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of...

Potentiators of glutamate receptors